Johnson & Johnson (JNJ) Assets Average (2009 - 2026)

Johnson & Johnson (JNJ) posted Assets Average of $200.1 billion for Q1 2026, up 2.06% sequentially from $196.0 billion in Q4 2025, and up 7.04% YoY from $186.9 billion in Q1 2025.

Johnson & Johnson (JNJ) Assets Average (2009 - 2026) Analysis & Trends

Johnson & Johnson (JNJ) has 18 years of Assets Average data on file, last reported at $200.1 billion in Q1 2026.

  • Quarterly Assets Average rose 7.04% year-over-year to $200.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $200.1 billion (up 7.04% YoY) and the FY2025 annual result came in at $189.7 billion, up 9.1% from the prior year.
  • Assets Average improved to $200.1 billion in Q1 2026 per JNJ's latest filing, from $196.0 billion in the prior quarter.
  • The five-year high for Assets Average was $200.1 billion in Q1 2026, with the low at $166.8 billion in Q4 2023.
  • Average Assets Average over 5 years is $183.5 billion, with a median of $180.4 billion recorded in 2022.
  • Year-over-year, Assets Average slipped 11.43% in 2024 and increased 10.09% in 2025.
  • Johnson & Johnson's Assets Average stood at $176.4 billion in 2022, then slipped by 5.45% to $166.8 billion in 2023, then gained by 7.43% to $179.2 billion in 2024, then climbed by 9.39% to $196.0 billion in 2025, then climbed by 2.06% to $200.1 billion in 2026.
  • Business Quant data shows JNJ's Assets Average at $200.1 billion in Q1 2026, $196.0 billion in Q4 2025, and $193.1 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 114.53 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 200.05 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 135.21 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 114.04 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 132.78 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 91.55 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 57.65 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 208.08 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn 29.46 Bn

Historic Data

Download Data
DateValue
Mar 29, 2026 200.05 Bn
Dec 28, 2025 196.01 Bn
Sep 28, 2025 193.10 Bn
Jun 29, 2025 193.53 Bn
Mar 30, 2025 186.89 Bn
Dec 29, 2024 179.20 Bn
Sep 29, 2024 179.69 Bn
Jun 30, 2024 176.53 Bn
Mar 31, 2024 169.76 Bn
Dec 31, 2023 166.81 Bn
Oct 1, 2023 178.87 Bn
Jul 2, 2023 193.83 Bn
Apr 2, 2023 191.67 Bn
Jan 1, 2023 181.25 Bn
Oct 2, 2022 176.42 Bn
Jul 3, 2022 178.04 Bn
Apr 3, 2022 180.19 Bn
Jan 2, 2022 180.62 Bn
Oct 3, 2021 177.83 Bn
Jul 4, 2021 174.50 Bn